Twitter Beğeni Hilesi

We are LIVE NOW! 🔽🔽🔽 bit.ly/4e0dEwj Experience CAR-T dans le myélome multiple FREE REGISTRATION!

#bloodcancerawarenessmonth by IACH

📢Welcome soon to the IACH program and supported sessions! View our exciting program ⬇️⬇️ iachlive.cme-congresses.com/program/ Register for the meeting ⬇️⬇️ bit.ly/3WAetF1 Mohamad Mohty

Join us for the upcoming IACH Journal Club: Human Leukocyte Antigen Mismatching and Survival- JCO 2024 🗓️September 9, 2024 ⏲️6PM CET, 12PM NY Register for FREE ⬇️⬇️ bit.ly/3Xv5EOE Florent Malard Arnon Nagler Mohamad Mohty

We are LIVE NOW! 🔽🔽🔽 bit.ly/3MvYWSh Bispecific Antibodies in Multiple Myeloma with Sara Scott and Katie Gatwood FREE REGISTRATION! Mohamad Mohty

👂Hear the latest IACH News: Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults by Prof. Mark Litzow ⬇️⬇️ clinical-hematology.org/iach-news/ Mark Litzow Mohamad Mohty Arnon Nagler

🔴 The 7th Annual Meeting of The IACH including the COMydAL, COLYM, and MPNCo&D tracks The Online Exhibition Hall is now open! Visit the exhibition 🔽 iachlive.cme-congresses.com/exhibition/ Register before Sept 12th to enjoy reduced registration rates🔽 bit.ly/3KA0ZVK Mohamad Mohty

📰We thank everyone for submitting their work for the e-poster presentation IACH The list of e-posters is available here 🔽🔽🔽 iachlive.cme-congresses.com/posters/ All e-posters will be uploaded by the start of the live meeting days Mohamad Mohty

📢 Join us for the upcoming 𝐈𝐀𝐂𝐇 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 𝐓𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐍𝐨𝐧-𝐇𝐨𝐝𝐠𝐤𝐢𝐧 𝐋𝐲𝐦𝐩𝐡𝐨𝐦𝐚: 𝐖𝐡𝐞𝐫𝐞 𝐃𝐨 𝐖𝐞 𝐒𝐭𝐚𝐧𝐝? 📅 Wednesday, Sept 11 ⏲ 6PM CET 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐟𝐨𝐫 𝐅𝐑𝐄𝐄 bit.ly/4dSXg1f Mohamad Mohty

Join us TOMORROW for IACH Journal Club: Human Leukocyte Antigen Mismatching and Survival- JCO 2024 ⏲️6PM CET, 12PM NY Register for FREE 🔽🔽🔽 bit.ly/3Xv5EOE Florent Malard Arnon Nagler Mohamad Mohty

IACH News of the week 8 | Sep | 2024 Mohamad Mohty IACH COMy clinical-hematology.org/news-of-the-we…

Thank you once again Profs. Mohamad Mohty, Florent Malard, and Arnon Nagler and IACH for the lively and interesting discussion of our results and their clinical context. The EBMT EBMT_Cellular_Therapy #immunogenetics #HCT #HLA

Learning from the best! HLA mismatching can reduce survival of the patients with blood neoplasms after HSCT „Class I but not Class II HLA mismatches especially at the Ag and PBM level, are associated withinferior survival in contemporarily unrelated HSCT Mohamad Mohty IACH

📢 Join us TOMORROW for an update on 𝐓𝐫𝐚𝐧𝐬𝐩𝐥𝐚𝐧𝐭 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐍𝐨𝐧-𝐇𝐨𝐝𝐠𝐤𝐢𝐧 𝐋𝐲𝐦𝐩𝐡𝐨𝐦𝐚: 𝐖𝐡𝐞𝐫𝐞 𝐃𝐨 𝐖𝐞 𝐒𝐭𝐚𝐧𝐝? ⏲️6PM CET, 12PM NY Register for free: bit.ly/4dSXg1f Mohamad Mohty

🩸🩸SEPTEMBER IS THE BLOOD CANCER AWARENESS MONTH🩸🩸 Curing blood cancers is the lifeblood of the IACH! clinical-hematology.org Mohamad Mohty